YU48666B - Mometason furoat monohidrat i postupak za njegovo dobijanje - Google Patents

Mometason furoat monohidrat i postupak za njegovo dobijanje

Info

Publication number
YU48666B
YU48666B YU149791A YU149791A YU48666B YU 48666 B YU48666 B YU 48666B YU 149791 A YU149791 A YU 149791A YU 149791 A YU149791 A YU 149791A YU 48666 B YU48666 B YU 48666B
Authority
YU
Yugoslavia
Prior art keywords
monohydrate
furoat
mometason
procedure
production
Prior art date
Application number
YU149791A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU149791A (sh
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48666(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Priority to SI9111497A priority Critical patent/SI9111497A/sl
Priority to HRP-1497/91A priority patent/HRP920383B1/xx
Publication of YU149791A publication Critical patent/YU149791A/sh
Publication of YU48666B publication Critical patent/YU48666B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU149791A 1990-09-10 1991-09-09 Mometason furoat monohidrat i postupak za njegovo dobijanje YU48666B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9111497A SI9111497A (sl) 1990-09-10 1991-09-09 Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo
HRP-1497/91A HRP920383B1 (en) 1990-09-10 1992-09-21 Mometasone furoate monohydrate, process for making the same and pharmaceutical compositions containing the said compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (2)

Publication Number Publication Date
YU149791A YU149791A (sh) 1994-01-20
YU48666B true YU48666B (sh) 1999-06-15

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
YU149791A YU48666B (sh) 1990-09-10 1991-09-09 Mometason furoat monohidrat i postupak za njegovo dobijanje

Country Status (35)

Country Link
US (1) US6180781B1 (OSRAM)
EP (1) EP0548114B1 (OSRAM)
JP (1) JPH0725789B2 (OSRAM)
KR (1) KR960013445B1 (OSRAM)
CN (1) CN1030920C (OSRAM)
AT (1) ATE113604T1 (OSRAM)
AU (1) AU663471B2 (OSRAM)
BG (1) BG60755B2 (OSRAM)
CA (1) CA2091360C (OSRAM)
CZ (1) CZ281318B6 (OSRAM)
DE (2) DE69104991T2 (OSRAM)
DK (1) DK0548114T5 (OSRAM)
EE (1) EE02962B1 (OSRAM)
ES (1) ES2065701T3 (OSRAM)
FI (1) FI111078B (OSRAM)
HK (1) HK185996A (OSRAM)
HR (1) HRP920383B1 (OSRAM)
HU (1) HU213401B (OSRAM)
IE (1) IE67056B1 (OSRAM)
IL (1) IL99437A (OSRAM)
LU (1) LU90366I2 (OSRAM)
MX (2) MX9203396A (OSRAM)
MY (1) MY106644A (OSRAM)
NL (1) NL980012I2 (OSRAM)
NO (1) NO300548B1 (OSRAM)
NZ (1) NZ239711A (OSRAM)
OA (1) OA09772A (OSRAM)
PH (1) PH30443A (OSRAM)
PL (1) PL165803B1 (OSRAM)
PT (1) PT98905B (OSRAM)
SI (1) SI9111497A (OSRAM)
TW (2) TW229208B (OSRAM)
WO (1) WO1992004365A1 (OSRAM)
YU (1) YU48666B (OSRAM)
ZA (1) ZA917148B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99437A (en) * 1990-09-10 1995-05-29 Schering Corp Mometasone furoate monohydrate process for making same and pharmaceutical compositions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
CA2305256C (en) * 1997-10-09 2005-05-17 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
JP5005127B2 (ja) 1999-05-04 2012-08-22 ストラカン・インターナショナル・リミテッド アンドロゲングリコシド及びそのアンドロゲン作用活性
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
BRPI0413330A (pt) * 2003-08-29 2006-10-10 Ranbaxy Lab Ltd inibidores de fosfodiesterase do tipo iv, composição farmacêutica contendo os mesmos e processo para sua preparação
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2435025B1 (en) 2009-05-29 2016-07-06 Pearl Therapeutics, Inc. Respiratory delivery of active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
IL99437A (en) * 1990-09-10 1995-05-29 Schering Corp Mometasone furoate monohydrate process for making same and pharmaceutical compositions

Also Published As

Publication number Publication date
EE02962B1 (et) 1997-02-17
IL99437A (en) 1995-05-29
NO930693L (no) 1993-02-26
NZ239711A (en) 1992-09-25
AU8497491A (en) 1992-03-30
IE67056B1 (en) 1996-02-21
OA09772A (en) 1993-11-30
HRP920383B1 (en) 2000-04-30
DE69104991T2 (de) 1995-04-20
IL99437A0 (en) 1992-08-18
IE913155A1 (en) 1992-03-11
CZ281318B6 (cs) 1996-08-14
LU90366I2 (fr) 1999-05-05
KR960013445B1 (ko) 1996-10-05
HRP920383A2 (en) 1998-06-30
SI9111497A (sl) 1998-04-30
NO930693D0 (no) 1993-02-26
EP0548114A1 (en) 1993-06-30
MX9203396A (es) 1992-07-31
CN1059911A (zh) 1992-04-01
JPH05506667A (ja) 1993-09-30
FI931031L (fi) 1993-03-09
ATE113604T1 (de) 1994-11-15
PH30443A (en) 1997-05-09
ZA917148B (en) 1992-08-26
BG60755B2 (bg) 1996-02-29
DE19875032I2 (de) 2007-04-19
CA2091360C (en) 1997-04-08
PL165803B1 (pl) 1995-02-28
TW229208B (OSRAM) 1994-09-01
DK0548114T5 (da) 1995-01-30
NO300548B1 (no) 1997-06-16
CA2091360A1 (en) 1992-03-11
WO1992004365A1 (en) 1992-03-19
FI111078B (fi) 2003-05-30
FI931031A0 (fi) 1993-03-09
MX9100990A (es) 1992-05-04
NL980012I1 (nl) 1998-05-06
CN1030920C (zh) 1996-02-07
ES2065701T3 (es) 1995-02-16
PT98905A (pt) 1992-09-30
YU149791A (sh) 1994-01-20
HU213401B (en) 1997-06-30
HUT64361A (en) 1993-12-28
HU9300685D0 (en) 1993-06-28
JPH0725789B2 (ja) 1995-03-22
EP0548114B1 (en) 1994-11-02
AU663471B2 (en) 1995-10-12
US6180781B1 (en) 2001-01-30
NL980012I2 (nl) 2004-11-01
MY106644A (en) 1995-07-31
PT98905B (pt) 1998-08-31
TW272195B (OSRAM) 1996-03-11
CZ38393A3 (en) 1994-01-19
HK185996A (en) 1996-10-11
DE69104991D1 (de) 1994-12-08

Similar Documents

Publication Publication Date Title
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
DE69012911D1 (de) Lautsprechersystem.
NO930615D0 (no) Hypoglykemiske hydroksyurinstoffderivater
TR24891A (tr) SELüLOZLARIN KLORSUZ OLARAK AGARTILMASINA MAHSUS USUL.
DE3885443D1 (de) Vorspannbares chirurgisches netzwerk.
GR1000023B (el) Καρβαμικος φαινυλεστηρ.
FI912409A0 (fi) Bicykliska 1-aza-cykloalkaner.
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
ITRM910086A1 (it) Complesso sterile per perforazioni auricolari.
GR890100033A (el) Μέ?οδος παρασκευής διδεοξυδιδευδροκαρβοκυκλικών νουκλεοσιδών.
ES2194003T3 (es) Huperzina a racemica.
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
YU47809B (sr) Novi ergolin-8-karboksamidi i postupak za njihovo dobijanje
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
DE69003780D1 (de) Laserquelle.
FI904676A0 (fi) Anordning foer loesgoerande av manteln i en haeftapparat.
DE69016447D1 (de) Digital-optisches tonsystem.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE69018326D1 (de) Hybridverstärker.
FI913838L (fi) Komplexa fosfater.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ATE90195T1 (de) Minoxidil-gel.
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida
NO904186D0 (no) Imidazoler.